美国 Escalon Medical 
Escalon Medical(NASDAQ:ESMC)是美国的一家医疗设备公司，主要生产治疗眼科疾病方面的医疗设备及相关药物。
Escalon Medical Corp. 开发, 销售和分销眼科诊断, 外科和药品以及血管通入设备，例如眼超，眼科数字影像系统，眼外科设备，血管导管等。



Escalon Medical Corp. (NASDAQ: ESMC) operates in the healthcare market specializing in the development, manufacture, marketing, and distribution of medical devices in two clinical areas: In Vitro Diagnostics and Ophthalmology.

The Company's Escalon Clinical Diagnostics group provides instrumentation and reagents for hematology, clinical chemistry, and hemoglobin analysis. The Company's Sonomed Escalon group is a leader in ophthalmic diagnostics imaging, providing ultrasound, digital photography, and image management systems.

Founded in 1987, Escalon Medical Corp. (NASDAQ: ESMC) operates in the healthcare market specializing in the development, manufacture, marketing, and distribution of medical devices in two clinical areas: In Vitro Diagnostics (IVD) and Ophthalmology.

The Company's Escalon Clinical Diagnostics group provides instrumentation and reagents for hematology, clinical chemistry, and hemoglobin analysis for monitoring diabetes. These products have previously been marketed under the Drew Scientific and JAS Diagnostics brands. Drew Scientific, Inc. is a wholly-owned subsidiary of Escalon Medical Corp., and has JAS Diagnostics as its subsidiary.

The Company's Sonomed Escalon group is a leader in ophthalmic diagnostics imaging, providing ultrasound, digital photography, and image management, and surgical solutions. These products have previously been marketed under the Sonomed, Escalon Digital Solutions, and Escalon / Trek Medical brands. Sonomed, Inc. and Escalon Medical Imaging are wholly-owned subsidiaries of Escalon Medical Corp.

The Company has its corporate headquarters in Wayne, Pennsylvania and operations in Long Island, New York, New Berlin, Wisconsin, Stoneham, Massachusetts, Dallas, Texas, Waterbury, Connecticut, Miami Lakes, Florida, and Barrow-in-Furness, UK.

The Company seeks to utilize strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the Company's distribution capabilities.